STOKE-ON-TRENT, England, Nov. 18 /PRNewswire-FirstCall/ -- Cancer patients will receive faster, more advanced cancer treatments as part of a major project to modernize the University Hospital radiotherapy department serving North Staffordshire in central England, while relocating it from the Royal Infirmary to City General Hospital.
The government-backed project entitled 'Fit for the Future' calls for the installation of four new linear accelerators from Varian Medical Systems (NYSE: VAR), three of which have the capability of delivering state-of-the-art RapidArc™ radiotherapy treatments. When treatments start in 2009, the center will have the ability to deliver fast and precise treatments with Varian RapidArc™ technology in combination with online 3D image guidance. RapidArc, introduced by Varian earlier this year, enables highly precise treatments to be delivered in less than two minutes.
Dr. Andy Moloney, head of radiotherapy physics and director of oncology, said, "We are delighted that this long-awaited project is finally going ahead and we selected Varian as a partner because they are technologically ahead of the game.
"We do a lot of intensity modulated radiotherapy treatments already and lack of speed can sometimes be a limiting factor for delivering such conformal treatments, so we believe our patients will benefit from the additional speed and efficiency of RapidArc," adds Dr. Moloney.
Under an order placed in August, Varian will supply Clinac® iX accelerators equipped with On-Board Imager® devices and RapidArc capability as well as a GammaMed® high dose rate brachytherapy afterloader, Acuity™ iX cone beam simulator and a suite of Eclipse™ treatment planning and ARIA™ oncology information software for combined management of chemotherapy and radiotherapy patients. The new machines are due to be installed beginning in March 2009.
RapidArc is a faster way of delivering advanced image-guided intensity-modulated radiotherapy (IMRT) that concentrates radiation dose on tumors while sparing more of the surrounding healthy tissue. It is up to eight times faster than conventional IMRT. Treatment planning analyses show that RapidArc matches or exceeds the precision of conventional IMRT systems for diseases including prostate and head and neck cancer. Other radiotherapy studies correlate the ability to spare more healthy tissue with reduced complications and better outcomes.
Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068 About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.
SOURCE: Varian Medical Systems, Inc.
CONTACT: Neil Madle, Varian Medical Systems, +44 7786 526068
Web site: http://www.varian.com/